Q3 2024 Aspira Women's Health Inc Earnings Call Transcript
Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated third quarter, 2024 earnings conference call.
(Operator Instructions)
At this time, I'd like to turn the call over to Nicole Sandford, Chief Executive Officer. Please go ahead.
'-&
Thank you and welcome everyone to our third quarter. 2024 earnings conference call with me today are Dr Sandra Milligan, our President and John Kasi, our interim Chief Financial Officer. I will begin with highlights from our progress in the third quarter, followed by Sandy with an update on our development strategy and then John with a review of our financials, we will answer questions submitted through the online platform.
I want to start with a brief discussion of our commercial performance for the quarter. We delivered more than 6,000 OvaSuite tests during the three months ended September 30th 2024, a 4% increase compared to the approximately 5,783 OvaSuite tests
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |